4Bikl D. Nonclassic actions of vitamin D [ J ]. J Clin Endocrinol Metab , 2009,94( 1 ) :26-34.
5Wylie-Rosett J, Albight AA, Apovian C, et al. 2006-2007 American Diabetes Association Nutrition Recommendations:issues for practice translation [ J ]. J Am Diet Assoc ,2007,107 ( 8 ) : 1296.
6Mogensen CE. Prediction of clinical diabetic nephropathy in IDDM patients. Alternatives to microalbuminuria? [ J ]. Diabetes, 1990,39 (7) :761.
7Chow FY,Paterson D J, Ozols E, et al. Monocyte chemoattractant pro- rein promotes the development of diabetic renal injm7 in strep tozoto- cin treatedmice [ J]. Kidney 1nt,2006,69( 1 ) :73-80.
8Ritz E,Stefanski A. Diabetic nephropathy in type 2 diabetes[ Jl. Am J Kidney Dis, 1996,27 : 167.
9Dalla Vestra M, Mussap M, Gallina P, et al. Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes [ J]. J Am Soc Nephrd ,2005,16 : S78-82.
10Navarro-Gonzalez JF, Mora-Femandez C. The Role of Inflammatory Cy- tok-Ines in Diabetic. Nephropathy[ J]. J Am Soc Nephro1,2008 ,19 :433- 442.
